Description

4-((2,6-Dichloropyridin-4-Yl)Methyl)Morpholine is a high-purity, advanced pharmaceutical intermediate characterized by its unique pyridine-morpholine hybrid structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex heterocyclic scaffolds. It is primarily utilized by research institutions and manufacturers in the pharmaceutical and agrochemical industries for developing next-generation small-molecule drugs and crop protection agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates, especially for central nervous system (CNS) and anti-infective therapies.
• Agrochemical Synthesis: Used in the research and development of novel pesticides and herbicides, leveraging its dichloropyridine moiety.
• Chemical Research & Development: Serves as a versatile precursor for creating new chemical entities (NCEs) in medicinal chemistry and material science.
• Ligand and Catalyst Development: The morpholine and pyridine nitrogen atoms make it a candidate for designing novel ligands in catalytic systems.
• Custom Synthesis Projects: Employed in contract research and manufacturing (CRAM) for bespoke chemical synthesis for client-specific targets.

Basic Information

Product Name	4-((2,6-Dichloropyridin-4-Yl)Methyl)Morpholine
CAS No.	1015844-22-0
Molecular Formula	C10H12Cl2N2O
Molecular Weight	247.12 g/mol
Synonyms	4-[(2,6-Dichloro-4-pyridinyl)methyl]morpholine; Morpholine, 4-[(2,6-dichloro-4-pyridinyl)methyl]-; 2,6-Dichloro-4-morpholinomethylpyridine; 4-(2,6-Dichloropyridin-4-ylmethyl)morpholine; 4-((2,6-Dichloropyridin-4-yl)methyl)morpholine
EINECS	Contact for details

Quality Control

Our 4-((2,6-Dichloropyridin-4-Yl)Methyl)Morpholine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, GC, and NMR, to ensure high chemical purity and identity confirmation. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specified parameters. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring traceability and consistency for critical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from strong oxidizing agents. For long-term storage, consider under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.